RELMADA THERAPEUTICS, INC. Annual Nonoperating Income (Expense) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Relmada Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2017 to 2023.
  • Relmada Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $1.05M, a 45.2% increase year-over-year.
  • Relmada Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $4.57M, a 73.4% increase year-over-year.
  • Relmada Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $4.91M, a 16.8% increase from 2022.
  • Relmada Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $4.21M.
  • Relmada Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$48.3K, a 103% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4.91M +$705K +16.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-19
2022 $4.21M +$4.25M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 -$48.3K -$1.43M -103% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $1.38M +$1.28M +1228% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-25
2019 $104K +$2.15M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-24
2018 -$2.04M -$2.98M -319% Jul 1, 2017 Jun 30, 2018 10-KT 2020-03-26
2017 $932K Jul 1, 2016 Jun 30, 2017 10-K 2018-09-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.